Jane Street Group LLC Increases Stock Position in VanEck Biotech ETF (NASDAQ:BBH)

Jane Street Group LLC raised its stake in shares of VanEck Biotech ETF (NASDAQ:BBH) by 401.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,348 shares of the company’s stock after acquiring an additional 6,684 shares during the period. Jane Street Group LLC owned approximately 0.33% of VanEck Biotech ETF worth $1,481,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Truvestments Capital LLC acquired a new position in VanEck Biotech ETF during the 3rd quarter worth about $44,000. FSA Wealth Management LLC purchased a new stake in VanEck Biotech ETF during the third quarter worth about $54,000. Coastline Trust Co acquired a new stake in shares of VanEck Biotech ETF during the third quarter worth about $59,000. Tyler Stone Wealth Management boosted its stake in shares of VanEck Biotech ETF by 79.5% in the third quarter. Tyler Stone Wealth Management now owns 1,472 shares of the company’s stock valued at $261,000 after purchasing an additional 652 shares during the period. Finally, Truist Financial Corp boosted its stake in shares of VanEck Biotech ETF by 3.8% in the second quarter. Truist Financial Corp now owns 2,703 shares of the company’s stock valued at $455,000 after purchasing an additional 100 shares during the period. 32.05% of the stock is owned by hedge funds and other institutional investors.

VanEck Biotech ETF Stock Down 0.6 %

Shares of BBH opened at $158.24 on Friday. VanEck Biotech ETF has a fifty-two week low of $151.35 and a fifty-two week high of $183.64. The firm’s 50 day moving average price is $166.60 and its 200 day moving average price is $172.53.

VanEck Biotech ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, December 24th. Stockholders of record on Monday, December 23rd were given a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.